BECTON, DICKINSON AND COMPANY Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two
BECTON, DICKINSON AND COMPANY (BDX) had Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two of $1.00 million as of 2013-09-30, per its 10-K filed 2013-11-27.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt
us-gaap:PrescriptionDrugSubsidyReceiptsYearTwo1 · last filed 2013-11-27
- 2013-09-30: Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two $1.00M.
- 2012-09-30: Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two $1.40M.
| Period end | Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two |
|---|---|
| 2013-09-30 | $1.00M 10-K · filed 2013-11-27 |
| 2012-09-30 | $1.40M 10-K · filed 2012-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |